Jeff Galvin, CEO of Addimmune, sits down with David Weisburd to discuss cell and gene therapy, and how Addimmune is working on a functional solution for HIV. We’re proudly sponsored by Bidav Insurance Group, visit lux-str.com if you’re ready to level up your insurance plans.
The Limited Partner podcast is part of the Turpentine podcast network. Learn more: turpentine.co
--
X / Twitter:
@jeffreygalvin (Jeff)
@dweisburd (David)
--
LINKS:
Addimmune: www.addimmune....
American Gene Technologies: www.americange...
--
SPONSOR: Bidav Insurance Group
The Limited Partner Podcast is proudly sponsored by Bidav Insurace Group.
Today's episode is sponsored by Bidav Insurance Group. Bidav Insurance Group is run by my close friend, Amit Bidav, who insures me both personally and at the corporate level.
Most people are not aware of the inherent conflicts in insurance, where insurance agents are incentivized to send their clients to the most expensive option. Amit has always been an incredible partner to me and 10X Capital, driving down our fees considerably while providing a premium solution. I am proud to personally endorse Amit and I ask that you consider using Bidav Insurance Group for your next insurance need, whether it be D&O, cyber, or even personal, car, and home insurance.
You could email Ahmet at ahmet@luxstr.com.
--
Questions or topics you want us to discuss on The Limited Partner podcast? Email us at david@10xcapital.com
--
TIMESTAMPS
(00:00) Episode Preview
(02:21) Jeff’s background
(05:08) Teaching at MIT as a teenager
(08:22) What is gene therapy?
(11:53) Episode Sponsor: Bidav Insurance Group
(12:39) Gene therapy success stories
(16:11) What is HIV?
(20:14) AGT103 and the quest for a functional HIV cure
(23:22) AGT103’s Phase I results
(29:43) How gene therapy could revolutionize pharmaceuticals
(30:52) How to contact Addimmune
16 сен 2024
